Pharmacology of mangostins and their derivatives: A comprehensive review

Chinese Journal of Natural Medicines

Volumn 15, Issue 2, 2017, Pages 81-93

  WANG, Ming Hui ^a   ZHANG, Kuo Jun ^a   GU, Qin Lan ^a   BI, Xiao Ling ^a   WANG, Jin Xin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Derivatives; Mangostins; Pharmacokinetics; Pharmacological activities; Toxicology

Indexed keywords

AMYLOID BETA PROTEIN; ANTINEOPLASTIC AGENT; CHOLINESTERASE; MANGOSTIN DERIVATIVE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIOXIDANT; CARDIOVASCULAR AGENT; MANGOSTIN; NEUROPROTECTIVE AGENT; PLANT EXTRACT; PROTECTIVE AGENT;

ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; AORTIC SMOOTH MUSCLE CELL; BRAIN CANCER; BREAST CANCER; CLINICAL PHARMACOLOGY; DIGESTIVE SYSTEM CANCER; DRUG EFFECT; ENTEROCOCCUS FAECALIS; ENZYME INHIBITION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUROPROTECTION; NONHUMAN; PROSTATE CANCER; REVIEW; SKIN CANCER; STREPTOCOCCUS MUTANS; STRUCTURE ACTIVITY RELATION; TOXICOLOGY; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; CHEMISTRY; FRUIT; GARCINIA MANGOSTANA; PHYTOTHERAPY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; CARDIOVASCULAR AGENTS; FRUIT; GARCINIA MANGOSTANA; HUMANS; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; XANTHONES;

EID: 85014870741     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(17)30024-9     Document Type: Review

References (117)

1. 1 Pedraza-Chaverri, J, Cardenas-Rodriguez, N, Orozco-Ibarra, M, et al. Medicinal properties of mangosteen (Garcinia mangostana) [J]. Food Chem Toxicol 46:10 (2008), 3227–3239.
2. 2 Hafeez, BB, Mustafa, A, Fischer, JW, et al. α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model [J]. Antioxid Redox Signal 21:5 (2014), 682–699.
3. 3 Jung, HA, Su, BN, Keller, WJ, et al. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen) [J]. J Agric Food Chem 54:6 (2006), 2077–2082.
4. 4 Dmitriy, Obolskiy, Ivo, Pischel, Nisarat, Siriwatanametanon, et al. Garcinia mangostana L.: A phytochemical and pharmacological review [J]. Phytother Res 23 (2009), 1047–1065.
5. 5 Rick, M Fairhurst, Gaurvika, ML Nayyar, Joel, G Breman, et al. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications [J]. Am J Trop Med Hyg 87:2 (2012), 231–241.
6. 6 Nordmann, P, Naas, T, Fortineau, N, et al. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010 [J]. Curr Opin Microbiol 10:5 (2007), 436–440.
7. 7 Sakagami, Y, Iinuma, M, Piyasena, K, et al. Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics [J]. Phytomedicine 12:3 (2005), 203–208.
8. 8 Iinuma, M, Tosa, H, Tanaka, T, et al. Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus [J]. J Pharm Pharmacol 48:8 (1996), 861–865.
9. 9 Chomnawang, MT, Surassmo, S, Wongsariya, K, et al. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus [J]. Fitoterapia 80:2 (2009), 102–104.
10. 10 Koh, JJ, Qiu, S, Zou, H, et al. Rapid bactericidal action of α-mangostin against MRSA as an outcome of membrane targeting [J]. Biochim Biophys Acta 1828:2 (2013), 834–844.
11. 11 Zou, H, Koh, JJ, Li, J, et al. Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity [J]. J Med Chem 56:6 (2013), 2359–2373.
12. 12 Koh, JJ, Lin, S, Aung, TT, et al. Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections [J]. J Med Chem 58:2 (2015), 739–752.
13. 13 Li, J, Liu, S, Koh, JJ, et al. A novel fragment based strategy for membrane active antimicrobials against MRSA [J]. Biochim Biophys Acta 1848:4 (2015), 1023–1031.
14. 14 Dharmaratne, HR, Sakagami, Y, Piyasena, KG, et al. Antibacterial activity of xanthones from Garcinia mangostana (L.) and their structure-activity relationship studies [J]. Nat Prod Res 27:10 (2013), 938–941.
15. 15 Dharmaratne, HR, Wijesinghe, WM, Thevanasem, V, Antimicrobial activity of xanthones from Calophyllum species, against methicillin-resistant Staphylococcus aureus (MRSA) [J]. J Ethnopharmacol 66:3 (1999), 339–342.
16. 16 Jeon, JG, Rosalen, PL, Falsetta, ML, et al. Natural products in caries research: current (limited) knowledge, challenges and future perspective [J]. Caries Res 45:3 (2011), 243–263.
17. 17 Nguyen, PT, Marquis, RE, Antimicrobial actions of α-mangostin against oral streptococci [J]. Can J Microbiol 57:3 (2011), 217–225.
18. 18 Nguyen, PT, Falsetta, ML, Hwang, G, et al. α-Mangostin disrupts the development of Streptococcus mutans biofilms and facilitates its mechanical removal [J]. PLoS One, 9(10), 2014, e111312.
19. 19 Murad, CF, Sassone, LM, Faveri, M, et al. Microbial diversity in persistent root canal infections investigated by checkerboard DNA-DNA hybridization [J]. J Endod 40:7 (2014), 899–906.
20. 20 Ruchadaporn, Kaomongkolgit, Kusuma, Jamdee, Jittima, Pumklin, et al. Laboratory evaluation of the antibacterial and cytotoxic effect of alpha-mangostin when used as a root canal irrigant [J]. Indian J Dent 4:1 (2013), 12–17.
21. 21 Nowakowska, Z, A review of anti-infective and anti-inflammatory chalcones [J]. Eur J Med Chem 42:2 (2007), 125–137.
22. 22 Suksamrarn, S, Suwannapoch, N, Phakhodee, W, et al. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana [J]. Chem Pharm Bull (Tokyo) 51:7 (2003), 857–859.
23. 23 Sudta, P, Jiarawapi, P, Suksamrarn, A, et al. Potent activity against multidrug-resistant Mycobacterium tuberculosis of α-mangostin analogs [J]. Chem Pharm Bull (Tokyo) 61:2 (2013), 194–203.
24. 24 Arunrattiyakorn, P, Suksamrarn, S, Suwannasai, N, et al. Microbial metabolism of α-mangostin isolated from Garcinia mangostana L. [J]. Phytochemistry 72:8 (2011), 730–734.
25. 25 Gopalakrishnan, G, Banumathi, B, Suresh, G, Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives [J]. J Nat Prod 60:5 (1997), 519–524.
26. 26 Kaomongkolgit, R, Jamdee, K, Chaisomboon, N, Antifungal activity of α-mangostin against Candida albicans [J]. J Oral Sci 51:3 (2009), 401–406.
27. 27 Upegui, Y, Robledo, SM, Gil Romero, JF, et al. In vivo antimalarial activity of α-mangostin and the new xanthone δ-mangostin [J]. Phytother Res 29:8 (2015), 1195–1201.
28. 28 Mahabusarakam, W, Kuaha, K, Wilairat, P, et al. Prenylated xanthones as potential antiplasmodial substances [J]. Planta Med 72:10 (2006), 912–916.
29. 29 Ignatushchenko, MV, Winter, RW, Bachinger, HP, et al. Xanthones as antimalarial agents; studies of a possible mode of action [J]. FEBS Lett 409:1 (1997), 67–73.
30. 30 Riscoe, M, Kelly, JX, Winter, R, Xanthones as antimalarial agents: discovery, mode of action, and optimization [J]. Curr Med Chem 12:21 (2005), 2539–2549.
31. 31 Kelly, JX, Winter, R, Peyton, DH, et al. Optimization of xanthones for antimalarial activity: the 3, 6-bis-omega-diethylaminoalkoxyxanthone series [J]. Antimicrob Agents Chemother 46:1 (2002), 144–150.
32. 32 Kelly, JX, Winter, RW, Cornea, A, et al. The kinetics of uptake and accumulation of 3, 6-bis-omega-diethylaminoamyloxyxanthone by the human malaria parasite Plasmodium falciparum [J]. Mol Biochem Parasitol 123:1 (2002), 47–54.
33. 33 Matsumoto, K, Akao, Y, Kobayashi, E, et al. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines [J]. J Nat Prod 66:8 (2003), 1124–1127.
34. 34 Matsumoto, K, Akao, Y, Yi, H, et al. Preferential target is mitochondria in α-mangostin-induced apoptosis in human leukemia HL60 cells [J]. Bioorg Med Chem 12:22 (2004), 5799–5806.
35. 35 Hung, SHS, Wu, KH, Liu, CH, et al. Mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway [J]. J Agric Food Chem 57 (2009), 1291–1298.
36. 36 Nakagawa, YI M, Naoe, T, Nozawa, Y, et al. Characterized mechanism of R-mangostin-induced cell death: Caspaseindependent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells [J]. Bioorg Med Chem 15 (2007), 5620–5628.
37. 37 Chen, JJ, Long, ZJ, Xu, DF, et al. Inhibition of autophagy augments the anticancer activity of α-mangostin in chronic myeloid leukemia cells [J]. Leuk Lymphoma 55:3 (2013), 628–638.
38. 38 Dunki-Jacobs, EM, Callender, GG, McMasters, KM, Current management of melanoma [J]. Curr Probl Surg 50:8 (2013), 351–382.
39. 39 Wang, JJ, Sanderson, BJ, Zhang, W, Cytotoxic effect of xanthones from pericarp of the tropical fruit mangosteen (Garcinia mangostana Linn.) on human melanoma cells [J]. Food Chem Toxicol 49:9 (2011), 2385–2391.
40. 40 Wang, JJ, Zhang, W, Babara, JS Sanderson, Altered mRNA expression related to the apoptotic effect of three xanthones on human melanoma SK-MEL-28 cell line [J]. Biomed Res Int, 2013(5392), 2013, 715603.
41. 41 Beninati, S, Oliverio, S, Cordella, M, et al. Inhibition of cell proliferation, migration and invasion of B16-F10 melanoma cells by α-mangostin [J]. Biochem Biophys Res Commun 450:4 (2014), 1512–1517.
42. 42 Wang, JJ, Sanderson, BJ, Zhang, W, Significant anti-invasive activities of α-mangostin from the mangosteen pericarp on two human skin cancer cell lines [J]. Anticancer Res 32:9 (2012), 3805–3816.
43. 43 Wang, SQ, Setlow, R, Berwick, M, et al. Ultraviolet A and melanoma: a review [J]. J Am Acad Dermatol 44:5 (2001), 837–846.
44. 44 Iwo, MI, Soemardji, AA, Hanafi, M, Sunscreen activity of α-mangostin from the pericarps of Garcinia mangostana Linn [J]. J Appl Pharm Sci 3 (2013), 70–73.
45. 45 Kaomongkolgit, R, Chaisomboon, N, Pavasant, P, Apoptotic effect of α-mangostin on head and neck squamous carcinoma cells [J]. Arch. Oral Biol 56:5 (2011), 483–490.
46. 46 Chao, AC, Hsu, YL, Liu, CK, et al. α-Mangostin, a dietary xanthone, induces autophagic cell death by activating the AMP-activated protein kinase pathway in glioblastoma cells [J]. J Agric Food Chem 59:5 (2011), 2086–2096.
47. 47 Chao, AC, Hsu, YL, Liu, CK, et al. r-Mangostin, a dietary xanthone, induces autophagic cell death by activating the AMP-activated protein kinase pathway in glioblastoma cells [J]. J Agric Food Chem 59 (2011), 2086–2096.
48. 48 Ibrahim, MY, Mohd Hashim, N, Mohan, S, et al. Involvement of NF-κB and HSP70 signaling pathways in the apoptosis of MDA-MB-231 cells induced by a prenylated xanthone compound, α-mangostin, from Cratoxylum arborescens [J]. Drug Des Devel Ther 8 (2014), 2193–2211.
49. 49 Ibrahim, MY, Hashim, NM, Mohan, S, et al. α-Mangostin from Cratoxylum arborescens demonstrates apoptogenesis in MCF-7 with regulation of NF-κB and HSP70 protein modulation in vitro, and tumor reduction in vivo [J]. Drug Des Devel Ther 8 (2014), 1629–1647.
50. 2/M cell cycle arrest and apoptosis through ROS mediated mitochondrial pathway and NF-κB suppression in MCF-7 cells [J]. J Func Foods 6 (2014), 290–304.
51. 51 Li, P, Tian, W, Ma, X, α-Mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells [J]. Mol Cancer, 13, 2014, 138.
52. 52 Won, YS, Lee, JH, Kwon, SJ, et al. α-Mangostin-induced apoptosis is mediated by estrogen receptor α in human breast cancer cells [J]. Food Chem Toxicol 66 (2014), 158–165.
53. 53 Leão, M, Gomes, S, Pedraza-Chaverri, J, et al. α-Mangostin and gambogic acid as potential inhibitors of the p53–MDM2 interaction revealed by a yeast approach [J]. J Nat Prod 76:4 (2013), 774–778.
54. 54 Shibata, MA, Iinuma, M, Morimoto, J, et al. α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn.) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation [J]. BMC Med, 9(1), 2011, 69.
55. 55 Johnson, JJ, Petiwala, SM, Syed, DN, et al. α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth [J]. Carcinogenesis 33:2 (2012), 413–419.
56. 56 Li, G, Petiwala, SM, Nonn, L, et al. Inhibition of CHOP accentuates the apoptotic effect of α-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells [J]. Biochem Biophys Res Commun 453:1 (2014), 75–80.
57. 57 Li, G, Petiwala, SM, Pierce, DR, et al. Selective modulation of endoplasmic reticulum stress markers in prostate cancer cells by a standardized mangosteen fruit extract [J]. PLoS One, 8(12), 2013, e81572.
58. 58 Shan, T, Cui, XJ, Li, W, et al. α-Mangostin suppresses human gastric adenocarcinoma cells in vitro via blockade of STAT3 signaling pathway [J]. Acta Pharmacol Sin 35:8 (2014), 1065–1073.
59. 59 Arakaki, J, Sunagawa, N, Chiba, I, et al. Inhibitory effect of α-mangostin on colon carcinogenesis induced by azoxymethane plus dextran sulfate sodium in CD1 (ICR) mice [J]. Cancer Res, 67(9 Supplement), 2007, 4974.
60. 60 Nabandith, V, Suzui, M, Morioka, T, et al. Inhibitory effects of crude α-mangostin, a xanthone derivative, on two different categorie of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat [J]. Asian Pac J Cancer Prev 5:4 (2004), 433–438.
61. 61 Aisha, AF, Abu-Salah, KM, Ismail, Z, et al. In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract [J]. BMC Complement Altern Med, 12(1), 2012, 104.
62. 62 Watanapokasin, R, Jarinthanan, F, Jerusalmi, A, et al. Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: caspase-dependent apoptosis induction in vitro and in mice [J]. Appl Biochem Biotech 162:4 (2010), 1080–1094.
63. 63 Chitchumroonchokchai, C, Thomas-Ahner, JM, Li, J, et al. Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites [J]. Mol Nutr Food Res 57:2 (2013), 203–211.
64. 64 Nakagawa, Y, Iinuma, M, Naoe, T, et al. Characterized mechanism of α-mangostin-induced cell death: Caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells [J]. Bioorg Med Chem 15:16 (2007), 5620–5628.
65. 65 Yoo, J-H, Kang, K, Jho, EH, et al. α-and γ-Mangostin inhibit the proliferation of colon cancer cells via β-catenin gene regulation in Wnt/cGMP signalling [J]. Food Chem 129:4 (2011), 1559–1566.
66. 66 Mizushina, Y, Kuriyama, I, Nakahara, T, et al. Inhibitory effects of α-mangostin on mammalian DNA polymerase, topoisomerase, and human cancer cell proliferation [J]. Food Chem Toxicol 59 (2013), 793–800.
67. 1 phase: Involvement of Ras, Hedgehog, NF-κB, and STAT3 signaling networks [J]. Cancer Res, 70(8 Supplement), 2010, 3800.
68. 68 Hafeez, BB, Fischer, JW, Mustafa, A, et al. α-Mangostin, a dietary xanthone, inhibits ectopic xenograft growth of pancreatic cancer cells in an athymic nude mice [J]. Cancer Res, 72(8 Supplement), 2012, 5418.
69. 69 Yuan, J, Wu, Y, Lu, G, α-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells [J]. Oncology Lett 5:6 (2013), 1958–1964.
70. 70 Xu, Q, Ma, J, Lei, J, et al. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by down-regulating the PI3K/Akt pathway [J]. BioMed Res Int, 2014(6), 2014, 546353.
71. 71 Lei, J, Huo, X, Duan, W, et al. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion [J]. Cancer Lett 347:1 (2014), 129–138.
72. 72 Shan, QM, Guo, K, Liu, J, et al. Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs [J]. Curr Mol Med 11:8 (2011), 666–677.
73. 73 Jazmin, M, Pe´rez-rojasl, CC, Dolores, J. Sa´nchez-gonzalez, et al. Renoprotection by α-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity [J]. Free Radic Res 43:11 (2009), 1122–1132.
74. 74 Sanchez-Perez, Y, Morales-Barcenas, R, Garcia-Cuellar, CM, et al. The α-mangostin prevention on cisplatin-induced apoptotic death in LLC-PK1 cells is associated to an inhibition of ROS production and p53 induction [J]. Chem Biol Interact 188:1 (2010), 144–150.
75. 75 Perez-Rojas, JM, Cruz, C, Garcia-Lopez, P, et al. Renoprotection by α-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity [J]. Free Radic Res 43:11 (2009), 1122–1132.
76. 76 Tangpong, J, Miriyala, S, Noel, T, et al. Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana [J]. Neuroscience 175 (2011), 292–299.
77. 77 Ren, Y, Matthew, S, Lantvit, DD, et al. Cytotoxic and NF-κB inhibitory constituents of the stems of Cratoxylum cochinchinense and their semisynthetic analogues [J]. J Nat Prod 74:5 (2011), 1117–1125.
78. 78 Ha, LD, Hansen, PE, Vang, O, et al. Cytotoxic geranylated xanthones and O-alkylated derivatives of α-mangostin [J]. Chem Pharm Bull (Tokyo) 57:8 (2009), 830–834.
79. 79 Fei, X, Jo, M, Lee, B, et al. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents [J]. Bioorg Med Chem Lett 24:9 (2014), 2062–2065.
80. 80 He, L, Zhu, C, Yuan, Y, et al. Specific glycosylated metabolites of α-mangostin by Cunninghamella blakesleana [J]. Phytochem Lett 9 (2014), 175–178.
81. 81 Boberg, KM, The significance of oxidized lipoproteins for the development of atherosclerosis. Antioxidants as a therapeutic alternative in atherosclerosis [J]. Tidsskr Nor Laegeforen 111:15 (1991), 1861–1865.
82. 82 Stocker, R, Keaney, JF Jr, Role of oxidative modifications in atherosclerosis [J]. Physiol Rev 84:4 (2004), 1381–1478.
83. 83 Williams, P, Ongsakul, M, Proudfoot, J, et al. Mangostin inhibits the oxidative modification of human low density lipoprotein [J]. Free Radic Res 23:2 (1995), 175–184.
84. 84 Mahabusarakam, W, Proudfoot, J, Taylor, W, et al. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin [J]. Free Radic Res 33:5 (2000), 643–659.
85. 2, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain [J]. Vasc Health Risk Manag 10 (2014), 523–531.
86. 86 Sargowo, D, Setiawan, M, Effect of extract from pericarp of mangosteen as antioxidant rats models of atherosclerosis [J]. Jurnal Kardiologi, 33, 2012, 71.
87. 87 Nishihama, Y, Ogamino, T, Shi, WL, et al. Synthetic studies of mangostin derivatives with an inhibitory activity on PDGF-induced human aortic smooth cells proliferation [J]. Heterocycles 77:2 (2009), 759–765.
88. 88 Devlin, CM, Leventhal, AR, Kuriakose, G, et al. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression [J]. Arterioscler Thromb Vasc Biol 28:10 (2008), 1723–1730.
89. 89 Okudaira, C, Ikeda, Y, Kondo, S, et al. Inhibition of acidic sphingomyelinase by xanthone compounds isolated from Garcinia speciosa [J]. J Enzym Inhib Med Chem 15:2 (2000), 129–138.
90. 90 Hamada, M, Iikubo, K, Ishikawa, Y, et al. Biological activities of α-mangostin derivatives against acidic sphingomyelinase [J]. Bioorg Med Chem Lett 13:19 (2003), 3151–3153.
91. 91 Yang, K, Zhang, KJ, Hu, SY, et al. Design, synthesis and biological activity of acid sphingomyelinase inhibitors [J]. Chem J Chin Univ 36:2 (2015), 279–286.
92. 92 Huang, L, Shi, A, He, F, et al. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors [J]. Bioorg Med Chem 18:3 (2010), 1244–1251.
93. 2+ dyshomeostasis [J]. Curr Med Chem 18:4 (2011), 552–576.
94. 94 Fernandez-Bachiller, MI, Perez, C, Monjas, L, et al. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties [J]. J Med Chem 55:3 (2012), 1303–1317.
95. 95 Reyes-Fermin, LM, Gonzalez-Reyes, S, Tarco-Alvarez, NG, et al. Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death [J]. Nutr Neurosci 15:5 (2012), 34–41.
96. 96 Pedraza-Chaverri, J, Reyes-Fermin, LM, Nolasco-Amaya, EG, et al. ROS scavenging capacity and neuroprotective effect of α-mangostin against 3-nitropropionic acid in cerebellar granule neurons [J]. Exp Toxicol Pathol 61:5 (2009), 491–501.
97. 97 Marquez-Valadez, B, Maldonado, PD, Galvan-Arzate, S, et al. α-Mangostin induces changes in glutathione levels associated with glutathione peroxidase activity in rat brain synaptosomes [J]. Nutr Neurosci 15:5 (2012), 13–19.
98. 98 Lin, J, Gao, Y, Li, H, et al. DNA protective effect of mangosteen xanthones: an in vitro study on possible mechanisms [J]. Adv Pharm Bull 4:2 (2014), 147–153.
99. 99 Khaw, KY, Choi, SB, Tan, SC, et al. Prenylated xanthones from mangosteen as promising cholinesterase inhibitors and their molecular docking studies [J]. Phytomedicine 21:11 (2014), 1303–1309.
100. 100 Ryu, HW, Oh, SR, Curtis-Long, MJ, et al. Rapid identification of cholinesterase inhibitors from the seedcases of mangosteen using an enzyme affinity assay [J]. J Agric Food Chem 62:6 (2014), 1338–1343.
101. 101 Phyu, MP, Tangpong, J, Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment [J]. Food Chem Toxicol 70 (2014), 151–156.
102. 102 Wang, Y, Xia, Z, Xu, JR, et al. α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates beta-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation [J]. Neuropharmacology 62:2 (2012), 871–881.
103. 103 Glabe, CG, Common mechanisms of amyloid oligomer pathogenesis in degenerative disease [J]. Neurobiol Aging 27:4 (2006), 570–575.
104. 104 Davies, P, Maloney, A, Selective loss of central cholinergic neurons in Alzheimer's disease [J]. The Lancet, 308(8000), 1976, 1403.
105. 105 Giacobini, E, Cholinesterase inhibitors: new roles and therapeutic alternatives [J]. Pharmacol Res 50:4 (2004), 433–440.
106. 106 Qin, J, Lan, W, Liu, Z, et al. Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents [J]. Chem Cent J, 7(1), 2013, 78.
107. 107 Rouleau, J, Iorga, BI, Guillou, C, New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid beta aggregation [J]. Eur J Med Chem 46:6 (2011), 2193–2205.
108. 108 Wang, QL, Yang, Ye, Wang, YT, et al. Identification of hepatoprotective xanthones from the pericarps of Garcinia mangostana, guided with tert-butyl hydroperoxide induced oxidative injury in HL-7702 cells [J]. Food & Funct 6:9 (2015), 3013–3021.
109. 109 Choi, YH, Bae, JK, Chae, HS, et al. α-Mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPARγ pathways in high-fat diet-induced obese mice [J]. J Agric Food Chem 63:38 (2015), 8399–8406.
110. 110 Taher, Muhammad, Amiroudine, MZ AM, Tengku Zakaria, TM FS, et al. α-Mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPARγ, GLUT4, and leptin expressions [J]. Evid Based Complement Alternat Med, 2015, 2015, 740238.
111. 111 Gutierrez-Orozco, F, Failla, ML, Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence [J]. Nutrients 5:8 (2013), 3163–3183.
112. 112 Jujun, P, Pootakham, K, Pongpaibul, Y, et al. Acute and repeated dose 28-day oral toxicity study of Garcinia mangostana Linn. rind extract [J]. CMU J Nat Sci 7 (2008), 199–208.
113. 113 Bunyong, R, Chaijaroenkul, W, Plengsuriyakarn, T, et al. Antimalarial activity and toxicity of Garcinia mangostana Linn. [J]. Asian Pac J Trop Med 7:9 (2014), 693–698.
114. 114 Hutadilok-Towatana, N, Reanmongkol, W, Wattanapiromsakul, C, et al. Acute and subchronic toxicity evaluation of the hydroethanolic extract of mangosteen pericarp [J]. J Med Plant Res 4 (2010), 969–974.
115. 115 Ibrahim, MY, Hashim, NM, Mohan, S, et al. α-Mangostin from Cratoxylum arborescens: an in vitro and in vivo toxicological evaluation [J]. Arab J Chem 8:1 (2015), 129–137.
116. 116 Xie, Z, Sintara, M, Chang, T, et al. Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trial [J]. Food Sci Nutr 3:4 (2015), 342–348.
117. 117 Xie, Z, Sintara, M, Chang, T, et al. Functional beverage of Garcinia mangostana (mangosteen) enhances plasma antioxidant capacity in healthy adults [J]. Food Sci Nutr 3:1 (2015), 32–38.